Oxana V Crysler ( Makarova-Rusher) MD, MHS

 labcoat
Clinical Associate Professor of Internal Medicine
Medical School
University of Michigan
Rogel Cancer Center
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
[email protected]
Available to mentor
Oxana V Crysler ( Makarova-Rusher) MD, MHS
labcoat
Clinical Associate Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Proceeding / Abstract / Poster
      Data from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.c.6651163
    • Journal Article
      PARP Inhibitor Therapy in Patients with IDH1 Mutated Cholangiocarcinoma
      Mohan A, Quingalahu E, Gunchic V, Kumar-Sinh C, Crysler O, Zalupski M, Sahai V. Oncologist, 2024 May 29;
    • Journal Article
      PARP Inhibitor Therapy in Patients with IDH1 Mutated Cholangiocarcinoma
      Mohan A, Quingalahu E, Gunchic V, Kumar-Sinh C, Crysler O, Zalupski M, Sahai V. Oncologist, 2024 May 29;
    • Journal Article
      Treatment Modalities for Locally Recurrent Rectal Cancer: A Review
      Regan S, Hendren S, Krauss J, Crysler O, Cuneo K. The Cancer Journal: The Journal of Principles & Practice of Oncology, 2024 May 1;
    • Proceeding / Abstract / Poster
      A phase Ib/II multicenter, randomized trial of gemcitabine and cisplatin +/- devimistat as first-line therapy for patients with advanced biliary tract cancer (BilT-04)
      Sahai V, Zhen D, Deming DA, Shroff RT, Hseih D, Kumar-Sinha C, Mahalingam D, Crysler OV, Alistar AT, Bajor D, Enzler T, Zalupski MM. 2024 Jun 1;
    • Journal Article
      First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
      Yarchoan M, Powderly JD, Bastos BR, Karasic TB, Crysler OV, Munster PN, McKean MA, Emens LA, Saenger YM, Ged Y, Stagg R, Smith S, Whiting CC, Moon A, Prasit P, Jenkins Y, Standifer N, Dubensky TW, Whiting SH, Ulahannan SV. Cancer Research Communications, 2024 Apr 1; 4 (4): 1100 - 1110. DOI:10.1158/2767-9764.CRC-24-0082
      PMID: 38551394
    • Proceeding / Abstract / Poster
      The impact of the COVID-19 Pandemic on Cancer Treatments: A SEER population-based Analysis
      Goyal A, Crysler O. 2024 Apr 5;
    • Journal Article
      Early Gastric Signet Ring Cell Adenocarcinoma as a Flat Pale Patch on an Esophagogastroduodenoscopy.
      Takakura W, Eswaran S, Chey WD, Ueyama H, Kwon R, Todisco A, Owens S, Stoffel E, Crysler OV, Bednar F, Hart BR. Am J Gastroenterol, 2024 Oct 10; DOI:10.14309/ajg.0000000000002780